3 unknown. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Unknown 3 |
Follow Semustine: new trials by email Literature Review of Semustine trials Research Report on Semustine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Single-arm Trial of Prophylactic Tocilizumab for Acute GVHD Prevention After Haploidentical HSCT. Cytarabine, Busulfan, Cyclophosphamide - Leukemia, Graft-versus-host-disease | Phase 2 | Unknown | Yi Luo | 46 | 2020-12-03 | 2023-02-21 |
| RIC Regimen for Elderly or High Comorbidity Burden Patients Receiving Haplo-HSCT Cytarabine - Acute Leukemia, Myelodysplastic Syndromes | Phase 2 | Unknown | Peking University People's Hospital | 50 | 2018-02-01 | 2024-03-26 |
| RIC Regimen for Low- and Intermediate-risk MDS Receiving Haplo-HSCT Cytarabine - Myelodysplastic Syndromes | Phase 2 | Unknown | Peking University People's Hospital | 50 | 2018-02-01 | 2022-04-20 |
Myelodysplastic Syndromes (2) · Graft vs Host Disease (1) · Leukemia (1)
Peking University People's Hospital (2) · Yi Luo (1)
China (3)
Xiao-Jun Huang (2) · Yi Luo (1)